Related references
Note: Only part of the references are listed.Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-kappa B and MAPK signaling pathways
Ping Zhou et al.
FASEB JOURNAL (2010)
Flavokawain B, a novel chalcone from Alpinia pricei Hayata with potent apoptotic activity: Involvement of ROS and GADD153 upstream of mitochondria-dependent apoptosis in HCT116 cells
Yu-Feng Kuo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Flavokawain B, a kava chalcone, induces apoptosis via up-regulation of death-receptor 5 and Bim expression in androgen receptor negative, hormonal refractory prostate cancer cell lines and reduces tumor growth
Yaxiong Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Effects of the Kava Chalcone Flavokawain A Differ in Bladder Cancer Cells with Wild-type versus Mutant p53
Yaxiong Tang et al.
CANCER PREVENTION RESEARCH (2008)
TRAIL death receptors as tumor suppressors and drug targets
Niklas Finnberg et al.
CELL CYCLE (2008)
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
Martee L. Hensley et al.
GYNECOLOGIC ONCOLOGY (2008)
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine lelomyosarcoma: A Gynecologic Oncology Group phase II trial
Martee L. Hensley et al.
GYNECOLOGIC ONCOLOGY (2008)
Natural products as sources of new drugs over the last 25 years
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2007)
Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies
Hyungjin Kim et al.
NATURE CELL BIOLOGY (2006)
Phase II trial of gemcitabine as second-line chemotherapy of uterine leiomyosarcoma: a Gynecologic Oncology Group (GOC) Study
KY Look et al.
GYNECOLOGIC ONCOLOGY (2004)
Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study
DG Gallup et al.
GYNECOLOGIC ONCOLOGY (2003)
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial
ML Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells
S Gupta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas - A Gynecologic Oncology Group study
DS Miller et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
Share Paper
